Meibomian gland epithelial cells demonstrate enhanced reliance on glycolysis for energy metabolism and differentiation
- 1Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei China
- 2Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
- 3Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX 77555 USA
Abstract
Background: Meibomian gland dysfunction is a leading cause of dry eye disease. Previous studies have established that the meibomian gland exists in a physiological hypoxic environment, with hypoxia-inducible factor 1α playing a regulatory role. However, the metabolic strategy of this gland remains unclear. This study aimed to test the hypothesis that glycolysis serves as an important metabolic pathway in meibomian gland epithelial cells in vivo and that these cells have an enhanced glycolytic phenotype during differentiation.
Methods: We combined clinical imaging, tissue analysis, and in vitro experiments to test our hypothesis.
Results: 18F-fluorodeoxyglucose positron emission tomography/computed tomography revealed significantly higher glucose uptake in human meibomian glands than in the orbicularis oculi muscle and surrounding subcutaneous connective tissues outside the tarsal plate, indicating substantial glycolytic activity in vivo. Immunofluorescence staining confirmed strong expression of glycolytic markers, including hypoxia-inducible factor 1α, glucose transporter type 1, hexokinase 2, 6-phosphofructo-2-kinase/fructose−2,6-biphosphatase 3, and pyruvate kinase M2, and lactate dehydrogenase A, in both human and mouse meibomian gland tissues. In immortalized human meibomian gland epithelial cells, differentiation induced a metabolic shift favoring glycolysis with increased extracellular acidification rate, elevated lactate production, and upregulated glycolytic enzyme expression. Three-dimensional spheroid cultures further revealed state-dependent metabolic heterogeneity.
Conclusion: The findings indicate that meibomian gland epithelial cells have a highly glycolytic phenotype in vivo and markedly enhanced glycolytic dependence during differentiation. These support their specialized secretory functions and adaptation to hypoxic microenvironments.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s40662-026-00518-9.
Related
- Intracrine androgen metabolism in the meibomian gland: regulation, circadian control, and implications in dry eye disease
- ADH5 K113 Lactylation is Associated with Enhanced Glycolysis and Bladder Epithelial Cell Proliferation in Cystitis Glandularis.
- Just spit it out! How airway secretome analysis can inform us about epithelial metabolism
- Mutant KRAS Reprograms Luminal Progenitor Differentiation to Establish a Novel Transformation-Competent Mammary Epithelial Cell State
- Dysregulation of epithelial differentiation architecture underlies field cancerization in head and neck cancer
BibTeX
@article{ren2026meibomian,
title = {{Meibomian gland epithelial cells demonstrate enhanced reliance on glycolysis for energy metabolism and differentiation}},
author = {Yaoyao Ren and Wenjing Li and Yuan Zhang and Yueli Tian and Shiya Yi and Xueling Tian and Yuehui Chen and Min Ke and Fan Xia and Yang Liu},
journal = {Eye and Vision},
year = {2026},
month = nov,
doi = {10.1186/s40662-026-00518-9},
url = {https://doi.org/10.1186/s40662-026-00518-9},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Meibomian gland epithelial cells demonstrate enhanced reliance on glycolysis for energy metabolism and differentiation
AU - Yaoyao Ren
AU - Wenjing Li
AU - Yuan Zhang
AU - Yueli Tian
AU - Shiya Yi
AU - Xueling Tian
AU - Yuehui Chen
AU - Min Ke
AU - Fan Xia
AU - Yang Liu
PY - 2026
DA - 2026/11/01
JO - Eye and Vision
DO - 10.1186/s40662-026-00518-9
UR - https://doi.org/10.1186/s40662-026-00518-9
AB - Background: Meibomian gland dysfunction is a leading cause of dry eye disease. Previous studies have established that the meibomian gland exists in a physiological hypoxic environment, with hypoxia-inducible factor 1α playing a regulatory role. However, the metabolic strategy of this gland remains unclear. This study aimed to test the hypothesis that glycolysis serves as an important metabolic pathway in meibomian gland epithelial cells in vivo and that these cells have an enhanced glycolytic phenotype during differentiation. Methods: We combined clinical imaging, tissue analysis, and in vitro experiments to test our hypothesis. Results: 18F-fluorodeoxyglucose positron emission tomography/computed tomography revealed significantly higher glucose uptake in human meibomian glands than in the orbicularis oculi muscle and surrounding subcutaneous connective tissues outside the tarsal plate, indicating substantial glycolytic activity in vivo. Immunofluorescence staining confirmed strong expression of glycolytic markers, including hypoxia-inducible factor 1α, glucose transporter type 1, hexokinase 2, 6-phosphofructo-2-kinase/fructose−2,6-biphosphatase 3, and pyruvate kinase M2, and lactate dehydrogenase A, in both human and mouse meibomian gland tissues. In immortalized human meibomian gland epithelial cells, differentiation induced a metabolic shift favoring glycolysis with increased extracellular acidification rate, elevated lactate production, and upregulated glycolytic enzyme expression. Three-dimensional spheroid cultures further revealed state-dependent metabolic heterogeneity. Conclusion: The findings indicate that meibomian gland epithelial cells have a highly glycolytic phenotype in vivo and markedly enhanced glycolytic dependence during differentiation. These support their specialized secretory functions and adaptation to hypoxic microenvironments. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s40662-026-00518-9.
SN - 2326-0254
ER -